Stock listing

Acadia Pharmaceuticals Inc.

Selected listing: DR6 · FWB · EUR · DE

Acadia Pharmaceuticals Inc. (Frankfurt:DR6), Health Technology. Latest release Sep 28, 2026: Acadia Pharmaceuticals Announces Allowance of U.S. Patent…

DR6:FWBEURDEUpdated October 2, 2026
Acadia Pharmaceuticals Inc. logo
Ticker
Frankfurt:DR6
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
Frankfurt
Currency
EUR

About Acadia Pharmaceuticals Inc.

The company focuses on developing innovative therapies for central nervous system disorders. Acadia is committed to advancing its pipeline to address unmet medical needs in this area.

Latest news from Acadia Pharmaceuticals Inc.

All Acadia Pharmaceuticals Inc. news →

Events

Replays

  • ACADIA Pharmaceuticals Inc. (ACAD) Q2 2026 Earnings Call

    Tue, Aug 04, 2026 · 04:30 PM ET

    Watch
  • ACADIA Pharmaceuticals Inc. (ACAD) Q1 2026 Earnings Call

    Wed, May 06, 2026 · 04:30 PM ET

    Watch
  • ACADIA Pharmaceuticals Inc. (ACAD) Q4 2025 Earnings Call

    Wed, Feb 25, 2026 · 04:30 PM ET

    Watch

Research Acadia Pharmaceuticals Inc.

Alternate listings